TEVA-GLICLAZIDE
TEVA-GLICLAZIDE
Approved
DIN Number
02238103
Drug Class
Human
Market Date
Jun 8, 1998
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02238103
AIG Number0119934001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BB09 GLICLAZIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
GLICLAZIDEActive
Strength: 80 MG
Monograph: GLICLAZIDE